India's Zydus Lifesciences set for best session in over a year on quarterly profit beat

Shares of Zydus Lifesciences ZYDU.NS up 4.4% to 927 rupees
Indian drugmaker posts surprise rise in profit by 1.8% to 10.42 bln rupees ($115.1 mln), beats analysts' expectation of a drop in profit to 9.32 bln rupees
Total rev from ops climbed 30.3%, led by a 16.4% growth in North American sales and nearly 13% jump in India sales
Stock set to rise most in a session since Jan 7, 2025
More than 1.4 mln shares traded, 2.6x their 30-day moving avg
Shares changed hands most since Nov 24, 2025
Avg rating of 28 analysts covering the stock is "hold" and median PT is 995 rupees, ~8% higher than current price - data compiled by LSEG
ZYDU fell 5.9% in 2025

($1 = 90.5590 Indian rupees)